Randomized Trials in Cardiovascular Imaging
نویسندگان
چکیده
منابع مشابه
Randomized Trials in Cardiovascular Imaging
A decade ago, cardiovascular imaging was buffeted by a perfect storm of disproportionate growth, unexplained geographic variability, skyrocketing costs, inadequate evidence base, and competition among specialties and modalities. Fortunately, the imaging community and, more broadly, the house of cardiology have appropriately responded to the crisis by fully embracing the concept of value over vo...
متن کاملBlindness in Randomized Controlled Trials
In combination with randomization, blinding or masking is an important factor in randomized controlled trials (RCTs), particularly in trials that assess therapeutic effects. Here an attempt is made to explain blindness and why it is important. In clinical trials, blinding is defined as the condition imposed on a study in which study participants, health care providers and assessors collecting o...
متن کاملAdvances in Cardiovascular Imaging Imaging Biomarkers in Atherosclerosis Trials
Atherosclerosis and its thrombotic complications are the leading cause of morbidity and mortality in developed countries, and the burden of atherosclerotic disease is expected to increase even further in the coming decades due to soaring obesity rates that feed the diabetes epidemic. There is, therefore, a clear need for new drugs targeting atherosclerosis to add to our current therapeutic arma...
متن کاملInfluence of noninvasive cardiovascular imaging in primary prevention: systematic review and meta-analysis of randomized trials.
BACKGROUND Despite extensive use in practice, the impact of noninvasive cardiovascular imaging in primary prevention remains unclear. METHODS We searched for randomized trials that compared imaging with usual care and reported any of the following outcomes in a primary prevention setting: medication prescribing, lifestyle modification (including diet, exercise, or smoking cessation), angiogra...
متن کاملTesting cardiovascular drug safety and efficacy in randomized trials.
Randomized trials provide the gold standard evidence on which rests the decision to approve novel therapeutics for clinical use. They are large and expensive and provide average but unbiased estimates of efficacy and risk. Concern has been expressed about how unrepresentative populations and conditions that pertain in randomized trials might be of the real world, including concerns about the ho...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: JACC: Cardiovascular Imaging
سال: 2017
ISSN: 1936-878X
DOI: 10.1016/j.jcmg.2017.02.001